Genomic screening in children: BabyScreen+

Gene: CASQ2

Green List (high evidence)

CASQ2 (calsequestrin 2, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000118729
EnsemblGeneIds (GRCh37): ENSG00000118729
OMIM: 114251, ClinGen, DECIPHER
CASQ2 is in 1 panel

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

ClinGen: 'strong actionability' both for adult and paediatric patients. Treatment: beta blockers first line; ICD. There are also numerous known arrhythmia triggers which can be avoided.

The mean age of onset of symptoms (usually a syncopal episode) of CPVT is between age seven and twelve years; onset as late as the fourth decade of life has been reported. Nearly 60% of patients have at least one syncopal episode before age 40. If untreated, CPVT is highly lethal, as approximately 30% of genetically affected individuals experience at least one cardiac arrest and up to 80% one or more syncopal spells. In untreated patients, the 8-year fatal or near-fatal event rates of 25% have been reported. Sudden death may be the first manifestation of the disease.
Created: 14 Aug 2025, 12:47 p.m. | Last Modified: 14 Aug 2025, 12:47 p.m.
Panel Version: 0.15
Sources: Expert list
Created: 14 Aug 2025, 12:41 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Ventricular tachycardia, catecholaminergic polymorphic, 2, MIM# 611938

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Expert list
Phenotypes
  • Ventricular tachycardia, catecholaminergic polymorphic, 2, MIM# 611938
Tags
cardiac treatable
OMIM
114251
ClinGen
CASQ2
DECIPHER
CASQ2
Clinvar variants
Variants in CASQ2
Penetrance
None
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
14 Aug 2025, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cardiac tag was added to gene: CASQ2. Tag treatable tag was added to gene: CASQ2.

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: casq2 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: CASQ2 were changed from to Ventricular tachycardia, catecholaminergic polymorphic, 2, MIM# 611938

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: casq2 has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services)

gene: CASQ2 was added gene: CASQ2 was added to Genomic screening in children: BabyScreen+. Sources: Expert list Mode of inheritance for gene: CASQ2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Review for gene: CASQ2 was set to GREEN